Church & Dwight's (NYSE:CHD) Q2 Sales Top Estimates

Household products company Church & Dwight (NYSE:CHD) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales were flat year on year at $1.51 billion. The company expects next quarter’s revenue to be around $1.53 billion, close to analysts’ estimates. Its non-GAAP profit of $0.94 per share was 9.7% above analysts’ consensus estimates.

Is now the time to buy Church & Dwight? Find out by accessing our full research report, it’s free.

Rick Dierker, Chief Executive Officer, commented, “Our brands continue to perform well in this dynamic environment. We continue to drive both dollar and volume share gains across most of our brands. Our balanced portfolio of value and premium products and our relentless focus on innovation continues to position us well for the future. Importantly, we began to see category growth levels improve sequentially through the second quarter, which provides further confidence in our full year outlook.

Company Overview

Best known for its Arm & Hammer baking soda, Church & Dwight (NYSE:CHD) is a household and personal care products company with a vast portfolio that spans laundry detergent to toothbrushes to hair removal creams.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.

With $6.07 billion in revenue over the past 12 months, Church & Dwight carries some recognizable products but is a mid-sized consumer staples company. Its size could bring disadvantages compared to larger competitors benefiting from better brand awareness and economies of scale.

As you can see below, Church & Dwight’s sales grew at a tepid 4.6% compounded annual growth rate over the last three years, but to its credit, consumers bought more of its products.

This quarter, Church & Dwight’s $1.51 billion of revenue was flat year on year but beat Wall Street’s estimates by 1.6%. Company management is currently guiding for a 1.5% year-on-year increase in sales next quarter.

Looking further ahead, sell-side analysts expect revenue to grow 2.6% over the next 12 months, a slight deceleration versus the last three years. This projection is underwhelming and indicates its products will see some demand headwinds.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Organic Revenue Growth

When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business’s performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations.

The demand for Church & Dwight’s products has generally risen over the last two years but lagged behind the broader sector. On average, the company’s organic sales have grown by 3.4% year on year.

In the latest quarter, Church & Dwight’s year on year organic sales were flat. This was a meaningful deceleration from its historical levels. We’ll be watching closely to see if Church & Dwight can reaccelerate growth.

Key Takeaways from Church & Dwight’s Q2 Results

It was encouraging to see Church & Dwight beat analysts’ revenue expectations this quarter. We were also happy its EPS outperformed Wall Street’s estimates. On the other hand, its EBITDA missed and its EPS guidance for next quarter fell short of Wall Street’s estimates. Overall, this was a mixed quarter. The stock remained flat at $93.58 immediately after reporting.

Church & Dwight didn’t show it’s best hand this quarter, but does that create an opportunity to buy the stock right now? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.